for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
US philanthropist tells FT that countries should inoculate ‘up to a point’ then donate to others
Deal for maker of Nature’s Bounty vitamins would mark latest push into health and nutrition
It is in the industry’s ‘collective interest’ to extend loans after government-backed schemes are wound down, report says